MichaelPHeffernanMD

PubMed

• 142 citations
  Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart Failure: The PACT-HF Randomized Clinical Trial.
  Harriette G.C. Van Spall, Shun Fu Lee, Feng Xie, Urun Erbas Oz, Richard Perez, Peter R. Mitoff, Manish Maingi, M Tjandrawidjaja, Michael P. Heffernan, Mohammad I. Zia,...> ;JAMA. 2019 Feb 26
• 7 citations
  Long-term Follow-up of the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI)
  Yaron Arbel, Dennis T. Ko, Andrew T. Yan, Warren J. Cantor, Akshay Bagai, Maria Koh, Maria Eberg, Mary Tan, David Fitchett, Bjug Borgundvaag, John Ducas, Michael P. He...> ;The Canadian Journal of Cardiology. 2018 Jun 1
• 20 citations
  Knowledge to action: Rationale and design of the Patient-Centered Care Transitions in Heart Failure (PACT-HF) stepped wedge cluster randomized trial.
  Harriette G.C. Van Spall, Shun Fu Lee, Feng Xie, Dennis T. Ko, Lehana Thabane, Quazi Ibrahim, Peter R. Mitoff, Michael P. Heffernan, Manish Maingi, M Tjandrawidjaja, M...> ;American Heart Journal. 2017 Dec 1
• 9 citations
  A Highly Sensitive and Drug-Tolerant Anti-Drug Antibody Screening Assay for Ixekizumab using Affinity Capture Elution
  Talia M. Muram, John H. Sloan, Jana S. Chain, Wendy J. Komocsar, Bruce I. Meiklejohn, Andrew Blauvelt, Kim A. Papp, Michael P. Heffernan, Yue-Wei Qian, Robert J. Konrad> ;The Journal of Investigative Dermatology. 2016 Jul 1
• 27 citations
  Safety and Efficacy of Open-label Subcutaneous Ixekizumab Treatment for 48 Weeks in a Phase II Study in Biologic-naive and TNF-IR Patients with Rheumatoid Arthritis.
  Mark C. Genovese, Daniel K. Braun, Janelle S Erickson, Pierre-Yves Berclaz, Subhashis Banerjee, Michael P. Heffernan, Hilde Carlier> ;The Journal of Rheumatology. 2016 Feb 1
• 4 citations
  Efficacy of Early Invasive Management After Fibrinolysis for ST-Segment Elevation Myocardial Infarction in Relation to Initial Troponin Status.
  Nigel S. Tan, Shaun G. Goodman, Warren J. Cantor, Juan J Russo, Bjug Borgundvaag, David Fitchett, Vladimír Džavík, Mary K. Tan, Basem Elbarouni, Shahar Lavi, Akshay Ba...> ;The Canadian Journal of Cardiology. 2015 Oct 1
• 53 citations
  Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis.
  Richard G. Langley, Phoebe Rich, Alan Menter, Gerald G. Krueger, Orin Goldblum, Y. Dutronc, Baojin Zhu, H. Wei, Gregory S Cameron, Michael P. Heffernan> ;Journal of the European Academy of Dermatology and Venereology. 2015 Sep 1
• 617 citations
  Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials
  Christopher E.M. Griffiths, Kristian Reich, Mark Lebwohl, Peter C.M. van de Kerkhof, Carle Paul, Alan Menter, Gregory S Cameron, J. Erickson, L. Zhang, Roberta J. Secr...> ;Lancet. 2015 Aug 8
• 22 citations
  A high level of clinical response is associated with improved patient‐reported outcomes in psoriasis: analyses from a phase 2 study in patients treated with ixekizumab
  Emily Edson-Heredia, Subhashis Banerjee, Baojin Zhu, Tomoko Maeda-Chubachi, Gregory S Cameron, Wei Shen, Michael P. Heffernan, Kenneth B. Gordon, Craig L. Leonardi> ;Journal of the European Academy of Dermatology and Venereology. 2016 May 1
• 80 citations
  A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis.
  Kenneth B. Gordon, Craig L. Leonardi, Mark Lebwohl, Andrew Blauvelt, Gregory S Cameron, Daniel K. Braun, J. Erickson, Michael P. Heffernan> ;Journal of the American Academy of Dermatology. 2014 Dec 1
• 43 citations
  IL-17 Induces Inflammation-Associated Gene Products in Blood Monocytes, and Treatment with Ixekizumab Reduces Their Expression in Psoriasis Patient Blood
  Claire Q.F. Wang, Mayte Suárez-Fariñas, Kristine E. Nograles, Claudia A. Mimoso, David Shrom, Ernst R. Dow, Michael P. Heffernan, Robert W Hoffman, James G. Krueger> ;The Journal of Investigative Dermatology. 2014 Dec 1
• 22 citations
  Increased uptake of guideline-recommended oral antiplatelet therapy: insights from the Canadian acute coronary syndrome reflective.
  Sumeet Gandhi, Brigita Zile, Mary K. Tan, Jhansi Saranu, Claudia Bucci, Andrew T. Yan, Patrick Robertson, Mackenzie A. Quantz, Eric Letovsky, Jean-François Tanguay, Je...> ;The Canadian Journal of Cardiology. 2014 Dec 1
• 90 citations
  Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular ...
  Hidehisa Saeki, Hidemi Nakagawa, T. Ishii, Y. Morisaki, Takehiro Aoki, P.-Y. Berclaz, Michael P. Heffernan> ;Journal of the European Academy of Dermatology and Venereology. 2015 Jun 1
• 2 citations
  Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention...
  Juan J Russo, Shaun G. Goodman, Warren J. Cantor, David Fitchett, Michael P. Heffernan, Bjug Borgundvaag, John Ducas, Eric A. Cohen, Vladimír Džavík, Shamir R. Mehta, ...> ;Heart. 2014 Jan 21
• 19 citations
  Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis...
  Akshay Bagai, Warren J. Cantor, Mary Tan, Wesley Tong, Andre Lamy, David Fitchett, Eric A. Cohen, Shamir R. Mehta, Bjug Borgundvaag, John Ducas, Michael P. Heffernan, ...> ;American Heart Journal. 2013 Apr 1
• 42 citations
  The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: results of a prospective, multicenter, open-label...
  Alice B. Gottlieb, Robert E. Kalb, Andrew Blauvelt, Michael P. Heffernan, Howard Sofen, Laura K. Ferris, Francisco A. Kerdel, S. Calabro, Jim Wang, Urs Kerkmann, Marc ...> ;Journal of the American Academy of Dermatology. 2012 Oct 1
• 4 citations
  Efficacy of early invasive management post-fibrinolysis in men versus women with ST-elevation myocardial infarction: a subgroup analysis from Trial of Routine Angiopla...
  Vineet Bhan, Warren J. Cantor, Raymond T. Yan, Shamir R. Mehta, Laurie J. Morrison, Michael P. Heffernan, David Fitchett, Vladimír Džavík, John Ducas, Bjug Borgundvaag...> ;American Heart Journal. 2012 Sep 1
• 3 citations
  Efficacy and safety of enoxaparin compared with unfractionated heparin in the pharmacoinvasive management of acute ST-segment elevation myocardial infarction: Insights...
  Shahar Lavi, Warren J. Cantor, Amparo Casanova, Mary K. Tan, Andrew T. Yan, Vladimír Džavík, David Fitchett, Eric A. Cohen, Bjug Borgundvaag, Michael P. Heffernan, Joh...> ;American Heart Journal. 2012 Feb 1
• Pruritic Scaly Rash on Arms and Legs —Quiz Case
  Ilana S. Rosman, Anne C. Lind, Michael J. Russell, Michael P. Heffernan> ;Archives of Dermatology. 2011 Nov 1
• 1 citations
  Persistent primary cutaneous primitive neuroectodermal tumor 4 years after chemotherapy.
  L Katie Morrison, H. Nicholas Shamma, Michael P. Heffernan> ;Journal of the American Academy of Dermatology. 2011 Aug 1
• 169 citations
  Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled Trial
  Craig A. Elmets, Jaye L. Viner, Alice P. Pentland, Wendy Cantrell, Hui Yi Lin, Howard H. Bailey, Sewon Kang, Kenneth G. Linden, Michael J. Heffernan, Madeleine Duvic, ...> ;Journal of the National Cancer Institute. 2010 Dec 15
• 10 citations
  Nephrogenic systemic fibrosis: a review.
  Amy Y.-Y. Chen, Matthew J. Zirwas, Michael P. Heffernan> ;Journal of Drugs in Dermatology. 2010 Jul 1
• 15 citations
  Innovative uses of rituximab in dermatology.
  David R. Carr, Michael P. Heffernan> ;Dermatologic Clinics. 2010 Jul 1
• 7 citations
  Combining traditional systemic and biologic therapies for psoriasis.
  Michael P. Heffernan> ;Seminars in Cutaneous Medicine and Surgery. 2010 Mar 1
• 8 citations
  Alefacept for psoriasis.
  Michael P. Heffernan, Craig L. Leonardi> ;Seminars in Cutaneous Medicine and Surgery. 2010 Mar 1
• Join now to see all

Journal Articles

• Safety and Efficacy of Open-label Subcutaneous Ixekizumab Treatment for 48 Weeks in a Phase II Study in Biologic-naïve and TNF-IR Patients with Rheumatoid Arthritis  
  Genovese MC, Braun DK, Erickson JS, Berclaz PY, Banerjee S, Heffernan MP, Carlier H, J Rheumatol., 1/15/2015
• A high level of clinical response is associated with improved patient-reported outcomes in psoriasis:analyses from a phase 2 study in patients treated with ixekizumab  
  Edson-Heredia E, Banerjee S, Zhu B, Maeda-Chubachi T, Cameron GS, Shen W, Heffernan MP, et al., J Eur Acad Dermatol Venereol, 1/13/2015
• Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials  
  Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickol..., Lancet, 1/8/2015
• Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis  
  Langley RG, Rich P, Menter A, Krueger G, Goldblum O, Dutronc Y, Zhu B, Wei H, Cameron GS, Heffernan MP, J Eur Acad Dermatol Venereol., 1/1/2015
• IL-17 induces inflammation-associated gene products in blood monocytes, and treatment with ixekizumab reduces their expression in psoriasis patient blood  
  Wang CQ, Suárez-Fariñas M, Nograles KE, Mimoso CA, Shrom D, Dow ER, Heffernan MP, et al., J Invest Dermatol., 1/1/2014
• The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: results of a prospective, multicenter, open-label...  
  Gottlieb AB, Kalb RE, Blauvelt A, Heffernan MP, et al., J Am Acad Dermatol., 1/1/2012
• Persistent Primary Cutaneous Primitive Neuroectodermal Tumor 4 Years after Chemotherapy  
  Morrison LK, Shamma HN, Heffernan MP, J Am. Acad. Dermatol, 1/1/2011
• Pruritic Scaly Rash on the Arms and Legs  
  Rosman IS, Lind AC, Russell MJ, Heffernan MP, Arch Dermatol., 1/1/2011
• Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double blind, placebo-controlled trial  
  Elmets CA, Viner JL, Pentland AP, Cantrell W, Lin HY, Bailey H, Kang S, Linden KG, Heffernan M, et al., J Natl Cancer Inst., 1/15/2010
• Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids  
  Kirsner RS, Heffernan MP, Antaya R, Acta Derm Venereol., 1/1/2010
• Combining traditional systemic and biologic therapies for psoriasis  
  Heffernan MP, Seminars in Cutaneous Medicine and Surgery, 1/1/2010
• Alefacept for psoriasis  
  Heffernan MP, Leonardi CL, Seminars in Cutaneous Medicine and Surgery, 1/1/2010
• Innovative uses of rituximab in dermatology  
  Carr DR, Heffernan MP, Dermatol Clin., 1/1/2010
• Nephrogenic Systemic Fibrosis:a Review  
  Chen AY, Zirwas MJ, Heffernan MP, J Drugs Dermatol., 1/1/2010
• Asymptomatic, edematous upper lip in a 39-year-old woman Cheilitis granulomatosa (CG)  
  Cernik C, Kerns MJ, Moa JC, Heffernan MP, Arch Dermatol., 1/1/2009
• Vitiligo after the resolution of psoriatic plaques during treatment with adalimumab  
  Smith DI, Heffernan MP, J Am Adad Dermatol, 1/1/2008
• Off-Label Uses of Biologics in Dermatology: rituximab, omalizuab, infliximab, etanercept, adalimuab, efalizumab and alefacept (Part 2 of 2)  
  Graves, JE, Sternhell K, Heffernan MP, J Am Acad Dermatol, 1/1/2007
• Adalimumab for Pyoderma Gangrenosum  
  Heffernan MP, Anadkat, MJ, Smith DI, Arch Dermatol., 1/1/2007
• A pilot study of the safety and efficacy of picolinicacid gel in the treatment of acne vularis  
  Heffernan MP, Nelson MM, Anadkat MJ, B J Dermatol, 1/1/2007
• A Single-Center, Open-Label, Prospective Pilot Study of Subcutaneous Efalizumab for Oral Erosive Lichen Planus  
  Heffernan MP, Smith DI, Bentley D, Tabacchi M, Graves, JE, J Drugs Dermatol., 1/1/2007
• Crusted violaceous plaques on an immunocompromised host  
  Xu LY, Bandow GD, Heffernan MP, Arch Dermatol., 1/1/2007
• Painful Nodule on Knee  
  Heffernan MP, Bentley DD, Tapia B, Klekotka P, Arch Dermatol., 1/1/2007
• Adalimumab Treatment is Associated with Improvement in Health-Related Quality of Life in Psoriasis: Patient-Reported Outcomes from a Phase II Randomized Controlled Trial  
  Shikiar R, Heffernan M, Langley RG, William MK, Okun M, Revicki DA, J Dermatol Treatment, 1/1/2007
• Off-label uses of rituximab in dermatology  
  Carr DR, Heffernan MP, Dermatol Ther., 1/1/2007
• Approach to the Acute, Generalized, Blistering Patient  
  Carr DR, Houshmand E, Heffernan MP, Seminars in Cutaneous Medicine and Surgery, 1/1/2007
• Join now to see all

Books/Book Chapters

• Fitzpatrick’s Dermatology in General Medicine 
  Chapter: CHAPTER 205 “Superficial Fungal Infections.” 
  Verma S, Heffernan MPEdition 7th,2007
• Fitzpatrick Dermatology in General Medicine 
  Chapter: CHAPTER 145 "Skin Manifestations of Bone Marrow and Blood Disorders" 
  Heffernan MP, Houshmand E, Rashid BAEdition 7th,2007
• Fitzpatrick Dermatology in General Medicine 
  Chapter: CHAPTER 206 "Yeast Infections: Candidiasis, Pityriasis (Tinea) Versicolor" 
  Janik MP, Heffernan MPEdition 7th,2007
• Conn’s Current Therapy. 
  Chapter: Papulosquamous Eruptions. 
  Ho J, Heffernan MPEdition 53rd,2001
• Washington Manual of Ambulatory Therapeutics 
  Chapter: Dermatology. 
  Heffernan MPEdition 1st,2001
• Dermatology in General Medicine 
  Chapter: Chapter 170; Cutaneous Changes in the Flushing Disorders and the Carcinoid Syndrome. 
  Hurst EA, Heffernan MPEditors: TFitzpatrick et al..McGraw-Hill, New YorkEdition 6th,
• Dermatology in General Medicine 
  Chapter: Chapter 205: Superficial Fungal Infection: Dermatophytosis, Onychomycosis, Tinea Nigra, Piedra. 
  Nelson MM, Martin AG, Heffernan MPEditors: TFitzpatrick et al..McGraw-Hill, New YorkEdition 6th,
• Dermatology in General Medicine 
  Chapter: Chapter 206; Candidiasis, Tinea (Pityriasis) Versicolor. 
  Klenck A, Martin AG, Heffernan MPEditors: TFitzpatrick et al..McGraw-Hill, New YorkEdition 6th,
• Join now to see all

Abstracts/Posters

• Off-Label Uses of Biologics.
  Heffernan MP, Utah Dermatology Society, Springdale, UT, 1/13/2010
• Efficacy, Safety and Health-Related Quality of Life of Infliximab Therapy in Plaque Psoriasis Patients Previously Treated with Etanercept: Analysis of PSUNRISE Study G...
  Gottlieb AB, Kalb R, Blauvelt A, Heffernan MP, Sofen H, Wang J, Calabro S, Kerkmann U, Chevrier M, and PSUNRISE Investigators, Poster Presentation at CPIN Mtg., Paris, France, 1/1/2010
• Practical Approaches to Patient Problems.
  Heffernan MP, AAD Annual Meeting, 1/1/2010
• Preliminary results on AAD formal leadership training programs for early career dermatologists.
  Morrison LK, Malone M, Carr D, Heffernan M, Marks V, American Academy of Dermatology Annual Meeting, 1/1/2010
• Cutaneous Epithelioid Angiosarcoma.
  Chen AY-Y, Moad JC, Heffernan MP, Ohio Dermatology Association, 1/1/2009
• The Safety and Efficacy of Tacrolimus Ointment and Pimecrolimus Cream in the Treatment of Atopic Dermatitis Patients Previously Treated with Corticosteroids: A Subset ...
  Kirsner R, Heffernan MP, Antaya, R, European Academy of Dermatology and Venereology Mtg, Paris, France, 1/1/2008
• The Safety and Efficacy of Tacrolimus Ointment and Pimecrolimus Cream in the Treatment of Atopic Dermatitis Patients Previously Treated with Corticosteroids: A Subset ...
  Kirsner R, Heffernan MP, Antaya, R, American Academy of Dermatology Mtg., Chicago, IL, 1/1/2008
• Non-Melanoma Skin Cancer Incidence Across Clinical Trials of Adalimumab in Psoriasis
  Langley RG, Yamauchi PS, Heffernan MP, Gu Y, Rozzo, SJ, European Academy of Dermatology Venereology Mtg., Istanbul, Turkey, 1/1/2008
• Pyoderma Gangrenosum Associated with Lenalidomide.
  Verma S, Kathula S, Heffernan MP, DAGMEC Resident Research Forum, 1/26/2007
• Atypical Granuloma Annulare with Associated Arthralgia.
  Kerns M, Shamma NH, Heffernan MP, DAGMEC Resident Research Forum, 1/26/2007
• Lamellar Ichthyosis: a classic presentation.
  Janik M, Heffernan MP, ODA Annual Meeting, Columbus, OH, 1/19/2007
• Resurgence of Bedbugs.
  Duffey M, Heffernan MP, ODA Annual Meeting, Columbus, OH, 1/19/2007
• Lipedematous alopecia and associated DLE.
  Odafe J, Kerns M, White M, Heffernan MP, ODA Annual Meeting, Columbus, OH, 1/19/2007
• Gardisil (HPV vaccine) reaction.
  Busse K, Kerns M, Heffernan MP, ODA Annual Meeting, Columbus, OH, 1/19/2007
• Nephrogenic systemic fibrosis and HIV: a report of 2 cases.
  Raffoul M, Kerns M, Moad J, Heffernan MP, ODA Annual Meeting, Columbus, OH, 1/19/2007
• Medical Dermatology Society Cooperative Trials Group Update: Advances in treatment for pyoderma gangrenosum, cutaneous sarcoidosis and severe lichen planus.
  Kerns MJ, McNicholas C, Trevino J, Heffernan MP, Central Research Forum, Wright State University, Dayton, OH, 1/1/2007
• Golfer’s Vasculitis: A Case of Recurrent Heat-induced Palpable Purpura in a 63-Year-Old-Female.
  M Bakos, D Channaiah, M Duffey, M Heffernan, Gross & Microscopic Symposium at the Annual Meeting of the American Academy of Dermatology, Washington, DC, 1/1/2007
• Paraneoplastic Pemphigus and the Sign of Leser-Trelat, A Novel Presentation.
  Rashid B, Darst M, Verma S, Heffernan MP, Dayton Area Graduate Medical Education Consortium, 1/1/2006
• Picolinic Acid Gel (PCL-016) in the Treatment of Acne Vulgaris. Poster 337.
  Heffernan MP, Anadkat MJ, Amin AN, Society for Investigative Dermatology, Providence, RI, 1/1/2004
• An Open Label Safety and Efficacy Study of Imiquimod 5% Cream for the Treatment of External Genital/ Perianal Warts in Subjects with Kidney or Liver Allogeneic Transpl...
  Anadkat MJ, Tobler CE, Heffernan MP, Society for Investigative Dermatology, Providence, RI, 1/1/2004
• Join now to see all

Lectures

• Biologics 2015 and Beyond. 
  18th Annual Winter Clinical Dermatology Meeting - 1/1/2015
• What the Sponsor Expects. 
  Coastal Dermatology Meeting - 1/1/2015
• Biologics Beyond Psoriasis. 
  Coastal Dermatology Meeting - 1/1/2015
• Practical Approaches to Psoriasis with Systemic Therapies. 
  Coastal Dermatology Meeting - 1/1/2015
• Practical Approaches to Patient Problems. 
  AAD Annual Meeting - 1/1/2015
• Boards and Beyond. 
  AAD Annual Meeting - 1/1/2014
• 2013 Medical Dermatology Society (MDS) Annual Meeting 
  Medical Dermatology Society (MDS), Miami Beach, Florida - 2/28/2013
• Managing Systemic Drugs in Dermatology. 
  Oregon Dermatology Society Meeting - 1/1/2011
• Off-Label Uses of Biologic Drugs in Dermatology. 
  Oregon Dermatology Society Meeting - 1/1/2011
• Recertification Exam Prep Course. 
  AAD Annual Meeting - 1/1/2011
• Dermatology Review. 
  Dept. of Medicine. St. Mary’s Dept. of Internal Medicine - 1/1/2010
• Psoriasis and Psoriatic Arthritis. 
  St Mary’s Hospital Dept. of Internal Medicine Grand Rounds - 1/1/2010
• Remote Patient Viewing Panelist. 
  Summer AAD Meeting - 1/1/2010
• Etanercept Lichen Planus Study. 
  American Academy of Dermatology, San Antonio, TX - 1/31/2008
• Biologic Drugs in Dermatology. 
  Health Education and Research Center, Charleston, WV - 1/25/2008
• Recent updates in the treatment of Psoriasis. 
  Ohio State University Medical Center, Columbus, OH - 1/23/2008
• Rituximab for Cutaneous Diseases. 
  American Academy of Dermatology, San Antonio, TX - 1/4/2008
• When a Dermatologist Needs a Surgeon and Vice Versa 
  Wright State University Department of Surgery City-Wide Surgical Grand Rounds, Kettering, OH - 1/1/2008
• Clinical Research in Medical Dermatology-What’s New? 
  Skin Disease Education Foundation, Waikola, HI - 1/1/2008
• Remicade in Dermatology. 
  Skin Disease Education Foundation, Waikola, HI - 1/1/2008
• Lipedematous Alopecia with Associated Discoid Lupus in an African American female: An emerging trend? 
  American Academy of Dermatology, San Antonio, TX - 1/1/2008
• Intravenous Immune Globulin. 
  American Academy of Dermatology, San Antonio, TX - 1/1/2008
• Advanced Medical Dermatology. 
  Symposia Course Director American Academy Dermatology, San Antonio, TX - 1/1/2008
• Tropical Dermatology, Managing Systemic Drugs in Dermatology and Great Cases. 
  University of Pittsburgh, Department of Dermatology Grand Rounds, Pittsburgh, PA - 1/14/2007
• Off Label Uses of Biologic Drugs in Dermatology. 
  Pittsburgh Dermatology Association, Pittsburgh, PA - 1/13/2007
• Join now to see all

Other

• Persistant Cutaneous Hyperpigmentation due to Hydroxychloroquinone One Year After Therapy Discontinuation. 
  Morrison LK, Nordlund JJ, Heffernan MP, Dermatology Online Journal
  1/1/2009
• Treatment Options for Atopic Dermatitis – 2007 Update. 
  Heffernan MP, Houshmand E, US Special Populations: Pediatrics Review
  1/1/2006
• Mycology #1. 
  Anadkat MJ, Kanzler MH, Gorsulowsky DC, Heffernan MP, National Library of Dermatologic Teaching Slides #50
  1/1/2004
• Mycology #2. 
  Anadkat MJ, Kanzler MH, Gorsulowsky DC, Heffernan MP, National Library of Dermatologic Teaching Slides #50
  1/1/2004
• Mycology #3. 
  Anadkat MJ, Kanzler MH, Gorsulowsky DC, Heffernan MP, National Library of Dermatologic Teaching Slides #50
  1/1/2004
• “Tropical Diseases” 
  Heffernan MP, National Library of Dermatologic Teaching Slides #45
  1/1/2001
• Join now to see all